MLLT3 and leukemia: Infants presented with fewer cases in the favorable cytogenetic groups, such as t(8;21) CBF leukemia and t(15;17) APL, with no NPM1 or CEBPA dm cases, whereas KMTAr cases were prevalent, mainly with t(9;11)/KMT2A-MLLT3.